1-5 of 5
Jean-Luc Coll
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4681: Unlocking the anticancer potential of calix[4]arene-based Cu(I) ionophores in vitro and in vivo

Free
Pierre Lelievre, Cyril Nogier, Nathan Renier, Jean-Luc Coll, Ivan Jabin, Lucie Sancey, Hennie Valkenier, Aurelien Deniaud, Benoit Busser
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 4681.
https://doi.org/10.1158/1538-7445.AM2024-4681
Published: 22 March 2024
View articletitled, Abstract 4681: Unlocking the anticancer potential of calix[4]arene-based Cu(I) ionophores in vitro and in vivo
Journal Articles

LIM Kinase Inhibitor Pyr1 Reduces the Growth and Metastatic Load of Breast Cancers

Free
Chloé Prunier, Véronique Josserand, Julien Vollaire, Evelyne Beerling, Christos Petropoulos, Olivier Destaing, Christopher Montemagno, Amandine Hurbin, Renaud Prudent, Leanne de Koning, Reuben Kapur, Pascale A. Cohen, Corinne Albiges-Rizo, Jean-Luc Coll, Jacco van Rheenen, Marc Billaud, Laurence Lafanechère
Journal: Cancer Research
Cancer Res (2016) 76 (12): 3541–3552.
https://doi.org/10.1158/0008-5472.CAN-15-1864
Published: 14 June 2016
View articletitled, LIM Kinase Inhibitor Pyr1 Reduces the Growth and Metastatic Load of Breast Cancers
Open the PDF for LIM Kinase Inhibitor Pyr1 Reduces the Growth and Metastatic Load of Breast Cancers in another window
Includes: Multimedia, Supplementary data
Journal Articles

Abstract 5399: Anti-cancer activity of a new LIM-Kinases inhibitor: “LIM-Pyr1”

Free
Chloé Prunier, Julien Vollaire, Véronique Josserand, Anoek Zomer, Amandine Hurbin, Renaud Prudent, Pascale Cohen, Jacco van Rheenen, Jean-Luc Coll, Marc Billaud, Laurence Lafanechère
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 5399.
https://doi.org/10.1158/1538-7445.AM2015-5399
Published: 01 August 2015
View articletitled, Abstract 5399: Anti-cancer activity of a new LIM-Kinases inhibitor: “LIM-Pyr1”
Journal Articles

ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and Invasion

Free
Julie A. Vendrell, Aurélie Thollet, Nhan T. Nguyen, Sandra E. Ghayad, Stéphanie Vinot, Ivan Bièche, Evelyne Grisard, Véronique Josserand, Jean-Luc Coll, Pierre Roux, Laura Corbo, Isabelle Treilleux, Ruth Rimokh, Pascale A. Cohen
Journal: Cancer Research
Cancer Res (2012) 72 (14): 3593–3606.
https://doi.org/10.1158/0008-5472.CAN-11-3095
Published: 15 July 2012
View articletitled, ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and Invasion
Open the PDF for ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and Invasion in another window
Includes: Supplementary data
Journal Articles

Reversal of P-glycoprotein-mediated multidrug resistance by siRNA in chemoresistant osteosarcoma cell lines

Free
Aurelie Dutour, Stephanie Napier, Eric Yvon, Jean Luc Coll, Raphael Rousseau
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 2277.
Published: 01 May 2007
View articletitled, Reversal of P-glycoprotein-mediated multidrug resistance by siRNA in chemoresistant osteosarcoma cell lines